Joshua A Selekman
Overview
Explore the profile of Joshua A Selekman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selekman J, Qiu J, Tran K, Stevens J, Rosso V, Simmons E, et al.
Annu Rev Chem Biomol Eng
. 2017 May;
8:525-547.
PMID: 28460183
High-throughput (HT) techniques built upon laboratory automation technology and coupled to statistical experimental design and parallel experimentation have enabled the acceleration of chemical process development across multiple industries. HT technologies...
2.
Selekman J, Lian X, Palecek S
Methods Mol Biol
. 2014 Feb;
1307:319-27.
PMID: 24500899
Human pluripotent stem cells (hPSCs), under the right conditions, can be engineered to generate populations of any somatic cell type. Knowledge of what mechanisms govern differentiation towards a particular lineage...
3.
Selekman J, Das A, Grundl N, Palecek S
Biotechnol Bioeng
. 2013 Jun;
110(11):3024-37.
PMID: 23740478
Human pluripotent stem cells (hPSCs) have an unparalleled potential for tissue engineering applications including regenerative therapies and in vitro cell-based models for studying normal and diseased tissue morphogenesis, or drug...
4.
Leydon C, Selekman J, Palecek S, Thibeault S
Tissue Eng Part A
. 2013 May;
19(19-20):2233-41.
PMID: 23672433
A satisfactory in vitro model of vocal fold mucosa does not exist, thus precluding a systematic, controlled study of vocal fold biology and biomechanics. We sought to create a valid,...
5.
Selekman J, Grundl N, Kolz J, Palecek S
Tissue Eng Part C Methods
. 2013 Apr;
19(12):949-60.
PMID: 23560510
Human pluripotent stem cells (hPSCs) have an unparalleled potential to generate limitless quantities of any somatic cell type. However, current methods for producing populations of various somatic cell types from...
6.
Hazeltine L, Selekman J, Palecek S
Biotechnol Adv
. 2013 Mar;
31(7):1002-19.
PMID: 23510904
Human pluripotent stem cells (hPSCs), including both embryonic stem cells and induced pluripotent stem cells, offer a potential cell source for research, drug screening, and regenerative medicine applications due to...
7.
Millili P, Selekman J, Blocker K, Johnson D, Naik U, Sullivan M
Microsc Res Tech
. 2010 Mar;
73(9):866-77.
PMID: 20232467
Polycationic polymers have been used to condense therapeutic DNA into submicron particles, offering protection from shear-induced or enzymatic degradation. However, the spontaneous nature of this self-assembly process gives rise to...